Skip to main content
. Author manuscript; available in PMC: 2019 Aug 1.
Published in final edited form as: J Gastrointest Surg. 2019 Jan 22;23(8):1604–1613. doi: 10.1007/s11605-018-04084-x

Figure 1:

Figure 1:

Figure 1:

Figure 1a: Cumulative incidence of endocrine insufficiency. 20.15% of patients developed endocrine insufficiency at mean 20.80 months follow-up.

Figure 1b: Cumulative incidence of endocrine insufficiency by diabetes type (IDDM = insulin-dependent diabetes mellitus, NIDDM = non-insulin dependent diabetes mellitus)